Home > Financial Ratios > AARTI DRUGS

AARTI DRUGS
EV/Core EBITDA

    Back to All Ratios
AARTI DRUGS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for AARTI DRUGS
Please provide your vote to see the results

AARTI DRUGS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 12.0913.9811.9513.0515.31

What is the latest EV/Core EBITDA ratio of AARTI DRUGS ?

The latest EV/Core EBITDA ratio of AARTI DRUGS is 12.09 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202512.09
Mar202413.98
Mar202311.95
Mar202213.05
Mar202115.31

How is EV/Core EBITDA of AARTI DRUGS Trending?

Years EV/Core EBITDA % Change
Mar2025 12.09
-13.52
Mar2024 13.98
16.99
Mar2023 11.95
-8.43
Mar2022 13.05
-14.76
Mar2021 15.31 -

Other Financial Ratios of AARTI DRUGS


Compare EV/Core EBITDA ratio of peers of AARTI DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AARTI DRUGS ₹4,123.1 Cr -4.7% -13.9% -2.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,211.0 Cr 1.6% 6% -2% Stock Analytics
DIVIS LABORATORIES ₹171,898.0 Cr -0.7% -1.9% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,377.0 Cr -0.8% 7.4% 21.2% Stock Analytics
CIPLA ₹122,349.0 Cr -0.4% -3.4% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹103,789.0 Cr 1.2% 0.3% -1.5% Stock Analytics


AARTI DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AARTI DRUGS

-4.7%

-13.9%

-2.7%

SENSEX

1%

2.5%

6.5%


You may also like the below Video Courses